With the imminent decision about spot Ethereum (CRYPTO: ETH) ETFs potentially shifting the limelight away from Bitcoin (CRYPTO: BTC), a crypto trader pointed out what several big names in traditional ...

It’s no secret that institutional investment managers must regularly file regulatory updates on the assets included in their portfolios (called 13F filings). Regulatory filings, among other ...

Shares have lost more than 60% of their value over the past year, potentially creating a buying opportunity. Perhaps there will come a time to buy, but the current valuation should scare off prudent ...

Activist investor Carl Icahn has tightened his hold on pharmaceutical company Bausch Health. Dana has entered an agreement to add two new board members picked by Carl Icahn’s company, one of whom is ...

The name Carl Icahn still has material cachet on Wall Street, though some of his most public investment battles happened decades ago. Icahn Enterprises (NASDAQ: IEP) is Carl Icahn's publicly traded ...